# Progestins and meningioma risk: patient testimonies

**In brief**: Ongoing story bringing together 3 events in Jura, followed from 9 November 2026 to 13 November 2026. 3 articles from 3 sources (health); last updated on 13 November 2026 at 17:30.

- Status: ongoing
- Category: Health
- Place: Jura
- First detected: 9 November 2026 at 06:30
- Updated: 13 November 2026 at 17:30
- Web page: https://acturadar.com/en/stories/663-progestins-and-meningioma-risk-patient-testimonies

## Timeline (3 events)

### 9 November 2026 — [Desogestrel pill and meningioma risk: patients in Jura ask questions](https://acturadar.com/en/events/13640-desogestrel-pill-and-meningioma-risk-patients-in-jura-ask-questions.md)

Women taking a desogestrel pill have received a letter informing them of a risk of intracranial meningioma. A woman from Jura and a midwife from the Upper Jura testify about their questions.

1 sources, 1 articles · Jura

### 9 November 2026 — [Giulia's battle, brain tumor after hormonal treatment with Lutényl](https://acturadar.com/en/events/14008-giulia-s-battle-brain-tumor-after-hormonal-treatment-with-lutenyl.md)

Giulia (pseudonym) developed a brain tumor after twelve years of hormonal treatment with Lutényl for endometriosis, without being informed of the increased risk. She has since been waging a long legal battle.

1 sources, 1 articles · Not located

### 13 November 2026 — [Testimony of a patient treated with Androcur and suffering from meningiomas](https://acturadar.com/en/events/19393-testimony-of-a-patient-treated-with-androcur-and-suffering-from-meningiomas.md)

Claire says she took Androcur for 18 years and developed meningiomas, while hundreds of thousands of women have been exposed to this anti-androgen in France.

1 sources, 1 articles · Nationwide

---

Cite as: Acturadar, “Progestins and meningioma risk: patient testimonies”, https://acturadar.com/en/stories/663-progestins-and-meningioma-risk-patient-testimonies
Methodology: https://acturadar.com/en/methodology